Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 11,950 |
| Other current assets | 120 |
| TOTAL | $12,070 |
| Non-Current Assets | |
| PPE Net | 60 |
| Other Non-Current Assets | 20 |
| TOTAL | $80 |
| Total Assets | $12,150 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 270 |
| Accrued Expenses | 230 |
| Other current liabilities | 9 |
| TOTAL | $510 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $510 |
| Shareholders' Equity | |
| Retained earnings | -6,390 |
| Other shareholders' equity | 18,020 |
| TOTAL | $11,630 |
| Total Liabilities And Equity | $12,140 |